These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12177236)
1. Study of the mechanism involved in angiogenesis and synovial cell proliferation in human synovial tissues of patients with rheumatoid arthritis using SCID mice. Nagashima M; Tanaka H; Takahashi H; Tachihara A; Tanaka K; Ishiwata T; Asano G; Yoshino S Lab Invest; 2002 Aug; 82(8):981-8. PubMed ID: 12177236 [TBL] [Abstract][Full Text] [Related]
2. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470. Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218 [TBL] [Abstract][Full Text] [Related]
3. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice. Huang ZH; Fan YF; Xia H; Feng HM; Tang FX World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo. Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788 [TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model. Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876 [TBL] [Abstract][Full Text] [Related]
6. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells. Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice. Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337 [TBL] [Abstract][Full Text] [Related]
8. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice. Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of angiogenesis inhibitor TNP-470 on human ACHN renal cell carcinoma. Zeng J; Mei W; Huang H; Li X; Kong P J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):331-3. PubMed ID: 12674772 [TBL] [Abstract][Full Text] [Related]
11. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis. Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532 [TBL] [Abstract][Full Text] [Related]
12. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470. Gervaz P; Scholl B; Padrun V; Gillet M Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478 [TBL] [Abstract][Full Text] [Related]
14. Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice. Zhou YF; Mori T; Kudo H; Asakai R; Sassa S; Sakamoto S Fertil Steril; 2003 Sep; 80 Suppl 2():788-94. PubMed ID: 14505755 [TBL] [Abstract][Full Text] [Related]
15. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. Nagashima M; Yoshino S; Ishiwata T; Asano G J Rheumatol; 1995 Sep; 22(9):1624-30. PubMed ID: 8523334 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo. Fan YF; Huang ZH World J Gastroenterol; 2002 Oct; 8(5):853-6. PubMed ID: 12378629 [TBL] [Abstract][Full Text] [Related]
17. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470. Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470. Shishido T; Yasoshima T; Denno R; Sato N; Hirata K Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice. Takei H; Lee ES; Cisneros A; Jordan VC Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127 [TBL] [Abstract][Full Text] [Related]
20. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]